LPS / Endotoxin Containment

Stage 2A/2B draft — not approved. Independently assessed from the published page retrieved on 7 October 2026. The canonical page and accepted mappings are unchanged.

1. Mission & Overview

Mission

Limit host exposure to bacterial endotoxin and related inflammatory microbial products.

Intervention Dominance: Diet-Supported — Dietary Requirements

Circulating concentration, biochemical activity, entry flux and inflammation are separate endpoints. Provisional prominence within the assessed/implemented draft; no comparative superiority over unassessed routes, routine dose or clinical benefit is established.

Overview

Lipopolysaccharide (LPS), often called bacterial endotoxin, is a component of the outer membrane of Gram-negative bacteria. The intestine encounters these bacterial products continually. Their movement into the body and persistence in an active form help determine the pressure placed on immune regulation. This PM concerns limiting that active exposure: barrier containment, lipid-associated transport and enzymatic inactivation contribute different parts of the process. Specific meal and fermentable-input studies identify possible dietary levers, while microbial composition and inflammation alone do not tell us how much endotoxin reached the host. [9] [19]

• Benefits: Restricting inappropriate bioactive exposure helps prevent persistent microbial stimulation; effective defence also requires recovery from immune tolerance. [19]
• Implementation Notes: Meal composition and preparation are testable routes; the available acute comparisons and mouse fibre protocols do not establish a routine intake prescription. [10] [11]
• Biological Relevance: This containment biology connects BRS5’s intestinal interface to BRS3 inflammatory responses, without equating a circulating LPS measurement with cognitive benefit.

2. Primary Biological Effects

Restriction of microbial-product entry; modification of lipid-associated transport; substrate-dependent microbial-product inactivation; limitation of persistent bioactive exposure.

3. Intervention Levers

4. Mechanistic Basis

Summary

Host exposure reflects entry, distribution, inactivation and clearance, rather than microbiome abundance alone.

Transport and inactivation

Junction permeability contributes one entry route. Chylomicron-associated transport provides another; experimental inhibition distinguishes it from paracellular leak. Intestinal alkaline phosphatase acts on particular substrates, whereas AOAH removes secondary acyl chains from LPS after exposure. [9] [7] [19]

Mechanism Boundary

Structural barrier maintenance belongs to PM1. SCFA production and signalling belong to PM5; the relevant containment consequence must be independently established here. Circulating LPS, LBP, GlycA, permeability probes and cytokines are different endpoints. General inflammation reduction is not a containment assay.

Integration

BRS5-FM1-PM1 — Epithelial Barrier Integrity supplies structural context. BRS3-FM1-PM2 — Gut-Derived Inflammatory Signalling concerns the downstream load and response. No upstream pool or constituent is inherited automatically.

4.1 Scientific Findings

Summary

Defined meal and diet studies support context-dependent endotoxin changes. Human oligofructose evidence adds a longer exposure result to mouse fermentable-input findings. Whole-pattern effects differ by assay and population: a prudent-pattern study changed endotoxin activity, whereas Mediterranean/Healthy Eating interventions did not change mean LBP. Enzyme chemistry also limits universal detoxification claims. These findings do not establish a single intake prescription or cognitive benefit.

5. BRS Pathways and Connections

5.1 BRS Pathways

• None listed.

5.2 Cross-BRS Mechanism Relationships

• BRS3-FM1-PM2 — Gut-Derived Inflammatory Signalling: containment affects the candidate source of gut-derived signals; downstream inflammatory regulation is separately assessed.

5.3 Local BRS Mechanism Relationships

• BRS5-FM1-PM1 — Gut Barrier / Tight-Junction Integrity: structural permeability supplies one containment route; lipid-carrier transport and substrate-dependent inactivation require additional evidence.
• BRS5-FM1-PM3 — Keystone Taxa Support: taxon composition is not itself an LPS containment measurement; a specific functional connection remains to be adjudicated.

7. Phenome Connections

These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework.

No phenome connection is admitted in this unapproved draft. The published attention and stress mappings remain in its review history. Jiang et al. measured microbiota profiles and ADHD associations, not PM2’s LPS containment or a stress intervention. [4]

8. References

• [1] Mohammad et al. (2021)
• [2] Brown et al. (2025)
• [3] Batey et al. (2024)
• [4] Jiang et al. (2018)
• [5] Goldberg et al. (2008)
• [6] Chen et al. (2010)
• [7] Komazin et al. (2019)
• [8] Igunnu et al. (2011)
• [9] Ghoshal et al. (2009)
• [10] Lyte et al. (2016)
• [11] Vors et al. (2017)
• [12] Zhang et al. (2020)
• [13] Krumbeck et al. (2018)
• [14] Wilms et al. (2019)
• [15] Tougaard et al. (2022)
• [16] Ghanim et al. (2011)
• [17] Chassaing et al. (2022)
• [18] Wellens et al. (2026)
• [19] Lu et al. (2008)
• [20] Cani et al. (2009)
• [21] Parnell et al. (2017)
• [22] Pendyala et al. (2012)
• [23] Umoh et al. (2016)
• [24] López-Moreno et al. (2017)